Abstract
Piriformis syndrome (PS) is an underdiagnosed but common cause of chronic buttock pain and sciatica. Anatomical variants of the piriformis muscle and sciatic nerve have not been thought to be significant in the pathophysiology of PS however, recent description of the piriformis musculotendinous junction has identified a common variant that we believe frequently results in dynamic sciatic nerve entrapment at the infra-piriformis fossa. We performed ultrasound guided low-dose Botulinum Toxin-A (BTX-A) injection to the lower piriformis muscle belly in an elite Australian Rules football player with PS and Type A piriformis muscle to relieve symptomatic sciatic nerve compression. Positive response to targeted BTX-A piriformis muscle injections support the hypothesis that sciatic nerve compression by Type A piriformis muscles may contribute to the pathophysiology of neuropathic PS, along with other functional factors. Sciatic nerve compression due to Type A piriformis at the infra-piriformis fossa has not been described previously and is a potentially common cause of neuropathic PS, especially when combined with other functional factors such as piriformis muscle spasm/hypertrophy and sacroiliac joint counternutation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beaton ABJ (1937) The relation of the sciatic nerve and of its subdivisions to the piriformis muscle. Anat Rec 70(1):1–5
Broadhurst NA, Simmons DN, Bond MJ (2004) Piriformis syndrome: correlation of muscle morphology with symptoms and signs. Arch Phys Med Rehabil 85:2036–2039
Durrani X, Winnie AP (1991) Piriformis muscle syndrome: an underdiagnosed cause of sciatica. J Pain Symptom Manag 6(6):374–379
Fernandez Hernando M, Cerezal L, Perez-Carro L et al (2015) Deep gluteal syndrome: anatomy, imaging and management of sciatic nerve entrapments in the subgluteal space. Skelet Radiol 44(7):919–934
Filler AG, Haynes JSE et al (2005) Sciatica of nondisc origin and piriformis syndrome: diagnosis by magnetic resonance neurography and interventional magnetic resonance imaging with outcome study of resulting treatment. J Neurosurg Spine 2:99–115
Fishman LM, Anderson C, Rosner B (2002) BOTOX and physical therapy in the treatment of piriformis syndrome. Am J Phys Med Rehabil 81(12):936–942
Fishman LM, Schaefer LP (2003) The piriformis syndrome is underdiagnosed. Muscle Nerve 28(3):646–649
Fishman LM, Wilkins AN, Rosner BA (2017) Electrophysiologically identified piriformis syndrome is successfully treated with incobotulinum toxin a and physical therapy. Muscle Nerve 56(2):258–263
Graboski CL, Gray DS, Burnham RS (2005) Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study. Pain 118(1–2):170–175
Indrekvam K, Sudman E (2002) Piriformis muscle syndrome in 19 patients treated by tenotomy—a 1- to 16-year follow-up study. Int Orthop 26(2):101–103
Jankovic D, Peng P, van Zundert A (2013) Brief review: piriformis syndrome: etiology, diagnosis and management. Can J Anesth 60:1003–1012
Kirschner JS, Foye PM, Cole JL (2009) Piriformis syndrome, diagnosis and treatment. Muscle Nerve 40(1):10–18
Michel F, Decavel P, Toussirot E et al (2013) The piriformis muscle syndrome: an exploration of anatomical and pathophysiological hypotheses and diagnostic criteria. Ann Phys Rehabil Med 56:300–311
Murphy M, Charlesworth J, Koh E (2017) The effects of Botulinum toxin injection in an elite sportsman with functional popliteal artery entrapment syndrome: a case report. Phys Ther Sport 27:7–11
Natsis K, Totlis T, Konstantinidis GA et al (2014) Anatomical variations between the sciatic nerve and the piriformis muscle: a contribution to the surgical anatomy in piriformis syndrome. Surg Radiol Anat 36(3):273–280
Rossi P, Cardinale P (2001) Magnetic resonance findings in piriformis syndrome: a case report. Arch Phys Med Rehabil 82(4):519–521
Smoll NR (2010) Variations of the piriformis and sciatic nerve with clinical consequence: a review. Clin Anat 23(1):8–17. https://doi.org/10.1002/ca.20893
Stewart J (2003) The piriformis syndrome is underdiagnosed. Muscle Nerve 28(3):644–646
Vleeming A, Stoeckart R, Snijders CJ et al (1989) The sacrotuberous ligament: a conceptual approach to its dynamic role in stabilizing the sacroiliac joint. Clin Biomech 4(4):200–203
Windisch G, Braun EM, Anderhuber F (2007) Piriformis muscle: clinical anatomy and consideration of the piriformis syndrome. Surg Radiol Anat 29(1):37–45
Yoon SJ, Ho J, Kang HY et al (2007) Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome. Pharmacotherapy 27(5):657–665
Acknowledgements
Mr. Dan Jolley, Strength and Conditioning Coach at Claremont Football Club for review of player training and GPS data.
Author information
Authors and Affiliations
Contributions
ESCK: study conception and design, manuscript writing and critical revision. DW: manuscript writing, data collection and critical revision. JB: manuscript writing and critical revision.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Koh, E., Webster, D. & Boyle, J. Case report and review of the potential role of the Type A piriformis muscle in dynamic sciatic nerve entrapment variant of piriformis syndrome. Surg Radiol Anat 42, 1237–1242 (2020). https://doi.org/10.1007/s00276-020-02440-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00276-020-02440-8